Business Description
Infinium Pharmachem Ltd
ISIN : INE0MRE01011
Share Class Description:
NSE:INFINIUM: Ordinary SharesTotal Employee Number:
144Compare
Compare
Traded in other countries / regions
INFINIUM.India IPO Date
2023-04-17Description
Infinium Pharmachem Ltd is engaged in the business of manufacturing and supplying Iodine, Iodine Derivatives and Active Pharmaceutical Ingredients (APIs). It provides fully integrated customized services from R & D to Commercial scale manufacturing and packaging for its products to the Pharmaceutical, Agrochemical, Nutraceutical, Speciality Chemicals and various other chemicals Industries.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.69 | |||||
Interest Coverage | 6.61 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 7.4 | |||||
Beneish M-Score | -2.44 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 14 | |||||
3-Year EBITDA Growth Rate | 7.4 | |||||
3-Year EPS without NRI Growth Rate | -25.4 | |||||
3-Year FCF Growth Rate | 167.5 | |||||
3-Year Book Growth Rate | 68.6 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 51.43 | |||||
9-Day RSI | 51.17 | |||||
14-Day RSI | 50.89 | |||||
3-1 Month Momentum % | -0.51 | |||||
6-1 Month Momentum % | -9.33 | |||||
12-1 Month Momentum % | -29.09 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.84 | |||||
Quick Ratio | 2.47 | |||||
Cash Ratio | 1.04 | |||||
Days Inventory | 117.36 | |||||
Days Sales Outstanding | 70.75 | |||||
Days Payable | 27.96 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.8 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 21.67 | |||||
Operating Margin % | 9.76 | |||||
Net Margin % | 6.41 | |||||
EBITDA Margin % | 12.5 | |||||
FCF Margin % | 12.68 | |||||
OCF Margin % | 17.79 | |||||
ROE % | 10.56 | |||||
ROA % | 6.47 | |||||
ROIC % | 10.07 | |||||
3-Year ROIIC % | 4.08 | |||||
ROC (Joel Greenblatt) % | 23.37 | |||||
ROCE % | 14.54 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 26.86 | |||||
PE Ratio without NRI | 26.86 | |||||
Price-to-Owner-Earnings | 11.45 | |||||
PEG Ratio | 0.94 | |||||
PS Ratio | 1.72 | |||||
PB Ratio | 2.7 | |||||
Price-to-Tangible-Book | 2.77 | |||||
Price-to-Free-Cash-Flow | 13.57 | |||||
Price-to-Operating-Cash-Flow | 9.67 | |||||
EV-to-EBIT | 17.26 | |||||
EV-to-EBITDA | 15.03 | |||||
EV-to-Revenue | 1.88 | |||||
EV-to-FCF | 14.82 | |||||
Price-to-GF-Value | 0.69 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.07 | |||||
Price-to-Graham-Number | 1.82 | |||||
| Price-to-Net-Current-Asset-Value | 5.82 | |||||
Earnings Yield (Greenblatt) % | 5.79 | |||||
FCF Yield % | 7.37 | |||||
Forward Rate of Return (Yacktman) % | 19.86 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Infinium Pharmachem Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 1,896.317 | ||
| EPS (TTM) (₹) | 7.8 | ||
| Beta | 1.0316 | ||
| 3-Year Sharpe Ratio | 0.34 | ||
| 3-Year Sortino Ratio | 1 | ||
| Volatility % | 22.85 | ||
| 14-Day RSI | 50.89 | ||
| 14-Day ATR (₹) | 6.791272 | ||
| 20-Day SMA (₹) | 209.265 | ||
| 12-1 Month Momentum % | -29.09 | ||
| 52-Week Range (₹) | 189.4 - 294 | ||
| Shares Outstanding (Mil) | 15.58 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Infinium Pharmachem Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Infinium Pharmachem Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| 2:1 Stock Split | 2023-09-13 | 247.50 (+0.20%) |
Show
Entries
Infinium Pharmachem Ltd Frequently Asked Questions
What is Infinium Pharmachem Ltd(NSE:INFINIUM)'s stock price today?
The current price of NSE:INFINIUM is ₹209.50. The 52 week high of NSE:INFINIUM is ₹294.00 and 52 week low is ₹189.40.
When is next earnings date of Infinium Pharmachem Ltd(NSE:INFINIUM)?
The next earnings date of Infinium Pharmachem Ltd(NSE:INFINIUM) is .
Does Infinium Pharmachem Ltd(NSE:INFINIUM) pay dividends? If so, how much?
Infinium Pharmachem Ltd(NSE:INFINIUM) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Infinium Pharmachem Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers